Title : Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.

Pub. Date : 2016 Aug 8

PMID : 27502582






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. Etoricoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 Etoricoxib is a COX-2 selective NSAID that has demonstrated efficacy in the treatment of RA at a dose of 90 mg. Etoricoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens